Citius Oncology, Inc. CTOR Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s net change in cash?
- Citius Oncology, Inc. (CTOR) reported net change in cash of -$4.66M in Q1 2026.
- How has Citius Oncology, Inc.'s net change in cash changed year-over-year?
- Citius Oncology, Inc.'s net change in cash decreased by 575.2% year-over-year, from $981.2K to -$4.66M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.